Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.2685824640511335e-12,6.66875,178.80163101852165,"['RPL34', 'RPLP1', 'RPL36A', 'RPL10A', 'RPL9', 'RPL7', 'RPS15A', 'RPS18', 'RPL38', 'RPS2', 'RPS11', 'RPS27A', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPL19', 'RPL41', 'RPL35A', 'RPS3A', 'RPL23A', 'RPS26', 'RPS25', 'RPS29', 'RPL37A', 'RPL26', 'FAU', 'RPS21']",9.051644031564023e-10,0,0,28
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.2026443750411255e-07,4.758195850739928,75.81506033064409,"['UQCRB', 'NDUFB10', 'NDUFA4', 'COX4I1', 'NDUFA3', 'NDUFB3', 'NDUFA1', 'ATP5MC3', 'UQCR11', 'UQCR10', 'COX5B', 'COX6C', 'COX7A1', 'COX7C', 'ATP5F1E', 'ATP5MC1', 'UQCRQ', 'NDUFS6', 'UQCRFS1', 'SLC25A5', 'ATP5MF']",2.3992755282070454e-05,0,0,21
3,Complement system WP2806,4.247385498868378e-06,7.500688340569734,92.77756628493034,"['FCGR3A', 'SELPLG', 'CD93', 'PROS1', 'C5AR1', 'ITGAX', 'F13A1', 'VSIG4', 'CALR', 'CD55', 'TLR2']",0.0005649022713494942,0,0,11
4,Nonalcoholic fatty liver disease WP4396,8.576749733434143e-05,2.9666542473919524,27.779366019343357,"['XBP1', 'UQCRB', 'NDUFB10', 'NDUFA4', 'INSR', 'COX4I1', 'NDUFA3', 'NDUFB3', 'NDUFA1', 'UQCR11', 'UQCR10', 'COX5B', 'COX6C', 'COX7A1', 'COX7C', 'UQCRQ', 'NDUFS6', 'MLX', 'CYCS', 'UQCRFS1']",0.008555307859100558,0,0,20
5,"GPCRs, Class A Rhodopsin-like WP455",0.00035297482143708425,6.9269153999692925,55.062839011706714,"['P2RY12', 'CX3CR1', 'P2RY13', 'CHRM3', 'CYSLTR1', 'HRH2', 'GPR65']",0.02816739075067932,0,0,7
6,Mitochondrial CIV Assembly WP4922,0.0006830633296379026,6.00146373918829,43.74420696186106,"['PET100', 'NDUFA4', 'COX4I1', 'COX14', 'COX5B', 'COX6C', 'COX7C']",0.045423711420920526,0,0,7
7,Mitochondrial complex III assembly WP4921,0.0015907849503768994,8.01441351888668,51.64109554897247,"['UQCRB', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10']",0.09067474217148326,0,0,5
8,Complement and Coagulation Cascades WP558,0.0032847169722067648,6.4095427435387675,36.652808583975904,"['C1QB', 'PROS1', 'C5AR1', 'PLAT', 'CD55']",0.1638252589888124,0,0,5
9,Photodynamic therapy-induced unfolded protein response WP3613,0.004495316679739181,5.825953370684981,31.48764181937378,"['DNAJC3', 'XBP1', 'HSPA5', 'CALR', 'HSP90B1']",0.1736099234571953,0,0,5
10,Spinal Cord Injury WP2431,0.005251066306806127,3.1299897091480258,16.43033046601582,"['C1QB', 'ZFP36', 'GAP43', 'FCGR2A', 'APEX1', 'TNFSF13', 'MIF', 'TLR4', 'TNFSF13B']",0.1736099234571953,0,0,9
11,Monoamine GPCRs WP58,0.005308372588633888,inf,inf,"['CHRM3', 'HRH2']",0.1736099234571953,0,0,2
12,Genes targeted by miRNAs in adipocytes WP1992,0.006526688851774259,12.782178217821782,64.31807416875624,"['HDAC4', 'TMSB4X', 'IGF1']",0.1736099234571953,0,0,3
13,Macrophage markers WP4146,0.006526688851774259,12.782178217821782,64.31807416875624,"['CD163', 'CD83', 'CD14']",0.1736099234571953,0,0,3
14,Platelet-mediated interactions with vascular and circulating cells WP4462,0.006526688851774259,12.782178217821782,64.31807416875624,"['SELPLG', 'TLR4', 'TLR2']",0.1736099234571953,0,0,3
15,Pyrimidine metabolism and related diseases WP4225,0.006526688851774259,12.782178217821782,64.31807416875624,"['NT5C', 'DPYD', 'TYMP']",0.1736099234571953,0,0,3
16,Endochondral Ossification with Skeletal Dysplasias WP4808,0.00782682024313187,4.050534703292095,19.64589916758776,"['HDAC4', 'SCIN', 'ENPP1', 'PLAT', 'IGF1', 'CALM2']",0.1837000751182127,0,0,6
17,Endochondral Ossification WP474,0.00782682024313187,4.050534703292095,19.64589916758776,"['HDAC4', 'SCIN', 'ENPP1', 'PLAT', 'IGF1', 'CALM2']",0.1837000751182127,0,0,6
18,Biomarkers for pyrimidine metabolism disorders WP4584,0.010807478677374499,9.585148514851484,43.396922027753035,"['NT5C', 'DPYD', 'TYMP']",0.22695705222486448,0,0,3
19,Development and heterogeneity of the ILC family WP3893,0.010807478677374499,9.585148514851484,43.396922027753035,"['IL15', 'ZBTB16', 'RORA']",0.22695705222486448,0,0,3
20,Nuclear Receptors Meta-Pathway WP2882,0.013272547939416549,2.0378990071527703,8.807916569047567,"['STAT3', 'PDGFB', 'NRG1', 'SLC5A3', 'SLC7A5', 'DNAJB1', 'SEC14L1', 'FTH1', 'BHLHE40', 'PDE4B', 'HMOX1', 'PLTP', 'CPEB4', 'HSPA1A', 'FKBP5']",0.2551710166433256,0,0,15
21,Adipogenesis WP236,0.013430053507543453,2.6291674257606124,11.332395935964133,"['CDKN1A', 'CEBPB', 'CEBPD', 'NAMPT', 'STAT3', 'RORA', 'MIF', 'IGF1', 'HIF1A']",0.2551710166433256,0,0,9
22,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.015153773325045212,25.52173913043478,106.92347190997423,"['CDKN1A', 'HIF1A']",0.25816354145320825,0,0,2
23,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.015471338944466907,4.0022365805168985,16.68438804940667,"['IFNAR2', 'OAS1', 'IKBKE', 'TLR4', 'TLR2']",0.25816354145320825,0,0,5
24,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.01552863407237343,5.117460317460317,21.31457839653374,"['FCGR2A', 'NLRP3', 'TMEM173', 'IKBKE']",0.25816354145320825,0,0,4
25,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.018852753471399013,3.7662261723775,14.95604682939932,"['IRAK2', 'LY96', 'PLAT', 'CD14', 'TLR4']",0.29184628745971514,0,0,5
26,Oxidative phosphorylation WP623,0.019017552566297228,2.6334358974358976,10.434707721026799,"['NDUFB10', 'NDUFS6', 'NDUFA4', 'NDUFA3', 'ATP5MC3', 'ATP5MF', 'ATP5F1E', 'ATP5MC1']",0.29184628745971514,0,0,8
27,Toll-like Receptor Signaling Pathway WP75,0.021079016558089664,2.408567134268537,9.29580996163223,"['IFNAR2', 'LY96', 'MAP3K8', 'CD14', 'TLR5', 'IKBKE', 'TLR4', 'MAP2K6', 'TLR2']",0.31150102246954725,0,0,9
28,Selenium Micronutrient Network WP15,0.022461661474482177,3.0755378486055776,11.674573618496622,"['SELENOM', 'PRDX5', 'INSR', 'SELENOW', 'PLAT', 'SELENOH']",0.3197332940795467,0,0,6
29,LTF danger signal response pathway WP4478,0.02323876072257357,6.3881188118811885,24.03167926944202,"['CD14', 'TLR4', 'TLR2']",0.3197332940795467,0,0,3
30,PI3K-Akt signaling pathway WP4172,0.026452273124262474,1.80972757095992,6.573678288103019,"['IFNAR2', 'CDKN1A', 'IL4R', 'ANGPT2', 'INSR', 'PDGFB', 'IGF1', 'HSP90B1', 'GNG10', 'CCND3', 'GNG3', 'FGF14', 'DDIT4', 'JAK3', 'TLR4', 'TLR2']",0.3518152325526909,0,0,16
31,Caloric restriction and aging WP4191,0.02884870904543367,12.75889328063241,45.23908075197993,"['NAMPT', 'IGF1']",0.35834903050317946,0,0,2
32,NRF2 pathway WP2884,0.03051211915037219,2.564071856287425,8.947665469504122,"['DNAJB1', 'FTH1', 'PDGFB', 'HMOX1', 'NRG1', 'SLC5A3', 'HSPA1A']",0.35834903050317946,0,0,7
33,Differentiation Pathway WP2848,0.03143412548273504,5.474681753889675,18.94163885886474,"['WNT5A', 'PDGFB', 'IGF1']",0.35834903050317946,0,0,3
34,"GPCRs, Other WP117",0.03143412548273504,5.474681753889675,18.94163885886474,"['CHRM3', 'ADGRE2', 'P2RY13']",0.35834903050317946,0,0,3
35,IL1 and megakaryocytes in obesity WP2865,0.03143412548273504,5.474681753889675,18.94163885886474,"['NLRP3', 'PLA2G7', 'TLR2']",0.35834903050317946,0,0,3
36,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.03666428238835051,2.280177777777778,7.538158808657976,"['HDAC4', 'WNT5A', 'STAT3', 'NRG1', 'IGF1', 'IKBKE', 'CALM2', 'MAP2K6']",0.38865577589911027,0,0,8
37,Lung fibrosis WP3624,0.037671372542603866,3.6530612244897958,11.977857410914599,"['CEBPB', 'PDGFB', 'HMOX1', 'IGF1']",0.38865577589911027,0,0,4
38,Gastric Cancer Network 2 WP2363,0.040934616290881354,4.78960396039604,15.306516759892103,"['PLAC8', 'RNF144B', 'S100A6']",0.38865577589911027,0,0,3
39,Genes controlling nephrogenesis WP4823,0.040934616290881354,4.78960396039604,15.306516759892103,"['ROBO2', 'CXCL12', 'PDGFB']",0.38865577589911027,0,0,3
40,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.040934616290881354,4.78960396039604,15.306516759892103,"['IL4R', 'STAT3', 'TLR4']",0.38865577589911027,0,0,3
41,CAMKK2  Pathway WP4874,0.04287057797248421,2.908006506416049,9.15896864634249,"['HDAC4', 'CHRM3', 'MAP1LC3A', 'HMOX1', 'CALM2']",0.38865577589911027,0,0,5
42,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.0457815074367373,8.504611330698287,26.2271585834458,"['CASP1', 'NLRP3']",0.38865577589911027,0,0,2
43,Complement Activation WP545,0.0457815074367373,8.504611330698287,26.2271585834458,"['C1QB', 'CD55']",0.38865577589911027,0,0,2
44,HIF1A and PPARG regulation of glycolysis WP2456,0.0457815074367373,8.504611330698287,26.2271585834458,"['TPI1', 'HIF1A']",0.38865577589911027,0,0,2
45,Insulin signaling in adipocytes (diabetic condition) WP3635,0.0457815074367373,8.504611330698287,26.2271585834458,"['TBC1D4', 'INSR']",0.38865577589911027,0,0,2
46,Insulin signaling in adipocytes (normal condition) WP3634,0.0457815074367373,8.504611330698287,26.2271585834458,"['TBC1D4', 'INSR']",0.38865577589911027,0,0,2
47,Nanomaterial-induced inflammasome activation WP3890,0.0457815074367373,8.504611330698287,26.2271585834458,"['CASP1', 'TLR4']",0.38865577589911027,0,0,2
48,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.04774043154535025,1.6931781787125013,5.150608430801471,"['IFNAR2', 'CDKN1A', 'IL4R', 'ANGPT2', 'INSR', 'PDGFB', 'IGF1', 'HIF1A', 'HSP90B1', 'GNG10', 'GNG3', 'FGF14', 'DDIT4', 'ITGAX', 'JAK3']",0.396842337220724,0,0,15
49,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.05170321057911702,4.256765676567657,12.60954197331145,"['STAT3', 'IGF1', 'TLR4']",0.42101185757280996,0,0,3
50,Toll-like Receptor Signaling related to MyD88 WP3858,0.053191257930097054,3.195436507936508,9.374967254034217,"['TLR5', 'IKBKE', 'TLR4', 'TLR2']",0.4244662382821745,0,0,4
51,Regulation of toll-like receptor signaling pathway WP1449,0.05586271192018846,1.8869596031183558,5.443610829640721,"['IFNAR2', 'IRAK2', 'LY96', 'MAP3K8', 'CD14', 'TLR5', 'IKBKE', 'TLR4', 'MAP2K6', 'TLR2']",0.42982077001306995,0,0,10
52,Glucocorticoid Receptor Pathway WP2880,0.056016741956590566,2.6648442677269717,7.68036010728537,"['MGAM', 'SEC14L1', 'BHLHE40', 'PDE4B', 'CPEB4']",0.42982077001306995,0,0,5
53,Oxidative Damage WP3941,0.062066542054308435,3.007002801120448,8.358109254904633,"['C1QB', 'CDKN1A', 'C5AR1', 'CYCS']",0.43496950364241865,0,0,4
54,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.06368710920405948,3.8304950495049503,10.548314242968706,"['TLR5', 'TLR4', 'TLR2']",0.43496950364241865,0,0,3
55,Transcription factor regulation in adipogenesis WP3599,0.06368710920405948,3.8304950495049503,10.548314242968706,"['CEBPB', 'CEBPD', 'INSR']",0.43496950364241865,0,0,3
56,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.06540894791615318,6.377470355731226,17.391975246629073,"['TLR4', 'TLR2']",0.43496950364241865,0,0,2
57,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.06540894791615318,6.377470355731226,17.391975246629073,"['CDKN1A', 'ENPP1']",0.43496950364241865,0,0,2
58,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.06540894791615318,6.377470355731226,17.391975246629073,"['GRM5', 'GRM7']",0.43496950364241865,0,0,2
59,Kynurenine Pathway and links to Cellular Senescence WP5044,0.06540894791615318,6.377470355731226,17.391975246629073,"['CDKN1A', 'TLR4']",0.43496950364241865,0,0,2
60,Transcriptional cascade regulating adipogenesis WP4211,0.06540894791615318,6.377470355731226,17.391975246629073,"['CEBPB', 'CEBPD']",0.43496950364241865,0,0,2
61,"COVID-19, thrombosis and anticoagulation WP4927",0.07292540042463024,inf,inf,['F13A1'],0.469310238216572,0,0,1
62,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.07292540042463024,inf,inf,['HRH2'],0.469310238216572,0,0,1
63,Cardiac Hypertrophic Response WP2795,0.07464261746763781,2.1933978372225384,5.6919631407337254,"['HDAC4', 'NRG1', 'IGF1', 'IKBKE', 'CALM2', 'MAP2K6']",0.4715643011472422,0,0,6
64,NRF2-ARE regulation WP4357,0.07682125206659333,3.4817281728172818,8.935068336964484,"['CEBPB', 'INSR', 'HMOX1']",0.4715643011472422,0,0,3
65,White fat cell differentiation WP4149,0.07682125206659333,3.4817281728172818,8.935068336964484,"['CEBPB', 'CEBPD', 'RORA']",0.4715643011472422,0,0,3
66,Differentiation of white and brown adipocyte WP2895,0.08724956169352557,5.1011857707509884,12.441704055955858,"['PLAC8', 'CEBPB']",0.5115260317437232,0,0,2
67,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.08724956169352557,5.1011857707509884,12.441704055955858,"['STAT3', 'HMOX1']",0.5115260317437232,0,0,2
68,Allograft Rejection WP2328,0.0884898227705195,2.2827321783584207,5.535323596730527,"['C1QB', 'CXCL12', 'GNLY', 'LRRK2', 'CD55']",0.5115260317437232,0,0,5
69,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.0884898227705195,2.2827321783584207,5.535323596730527,"['BEX3', 'CDKN1A', 'HSPA5', 'NRG1', 'YBX3']",0.5115260317437232,0,0,5
70,Acute viral myocarditis WP4298,0.08974140907784618,2.0741897275761816,5.000504253434151,"['STAT3', 'CASP1', 'CYCS', 'TLR5', 'TLR4', 'CD55']",0.5115260317437232,0,0,6
71,Immune response to tuberculosis WP4197,0.09103133294109977,3.1910891089108913,7.647609434296263,"['IFNAR2', 'OAS1', 'PTPN2']",0.5115704484999832,0,0,3
72,Notch Signaling Pathway Netpath WP61,0.09786051939417877,2.2036745046959623,5.121806916570428,"['CDKN1A', 'STAT3', 'RBPJ', 'HIF1A', 'SAP30']",0.5395138927630017,0,0,5
73,NO/cGMP/PKG mediated Neuroprotection WP4008,0.10463709657873192,2.432728647014361,5.491294104314623,"['TSPO', 'CYCS', 'GRIN2B', 'CALM2']",0.5395138927630017,0,0,4
74,Bladder cancer WP2828,0.10623637291937515,2.9451637471439454,6.60331845807966,"['CDKN1A', 'RPS6KA5', 'TYMP']",0.5395138927630017,0,0,3
75,Unfolded protein response WP4925,0.10623637291937515,2.9451637471439454,6.60331845807966,"['XBP1', 'HSPA5', 'TXNIP']",0.5395138927630017,0,0,3
76,Cori Cycle WP1946,0.11087754187109307,4.250329380764163,9.347872297136801,"['TPI1', 'PGAM1']",0.5395138927630017,0,0,2
77,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.11087754187109307,4.250329380764163,9.347872297136801,"['CYSLTR1', 'LTC4S']",0.5395138927630017,0,0,2
78,Fluoropyrimidine Activity WP1601,0.11087754187109307,4.250329380764163,9.347872297136801,"['DPYD', 'TYMP']",0.5395138927630017,0,0,2
79,"NAD metabolism, sirtuins and aging WP3630",0.11087754187109307,4.250329380764163,9.347872297136801,"['NAMPT', 'HIF1A']",0.5395138927630017,0,0,2
80,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.11087754187109307,4.250329380764163,9.347872297136801,"['STAT3', 'JAK3']",0.5395138927630017,0,0,2
81,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.11087754187109307,4.250329380764163,9.347872297136801,"['PDGFB', 'IGF1']",0.5395138927630017,0,0,2
82,Overview of nanoparticle effects WP3287,0.11087754187109307,4.250329380764163,9.347872297136801,"['CCND3', 'HMOX1']",0.5395138927630017,0,0,2
83,Regulatory circuits of the STAT3 signaling pathway WP4538,0.1180234022235641,2.0608606425960367,4.40379612488512,"['PTPRT', 'IFNAR2', 'STAT3', 'JAK3', 'CSF2RA']",0.567365511894001,0,0,5
84,Neovascularisation processes WP4331,0.12235090543968584,2.7343705799151343,5.744535487840653,"['CXCL12', 'PDGFB', 'HIF1A']",0.5688035374703755,0,0,3
85,Mitochondrial complex I assembly model OXPHOS system WP4324,0.12878380430448233,1.9961481113320079,4.09134552350718,"['NDUFB10', 'NDUFS6', 'NDUFA3', 'NDUFB3', 'NDUFA1']",0.5688035374703755,0,0,5
86,Calcium Regulation in the Cardiac Cell WP536,0.1340022518065354,1.5996993987975952,3.215233701475348,"['RGS4', 'CHRM3', 'RYR2', 'GNG3', 'CACNA1B', 'CALM3', 'CALR', 'CALM2', 'YWHAH']",0.5688035374703755,0,0,9
87,Vitamin D Receptor Pathway WP2877,0.1340620603517093,1.825839499146272,3.6689376535753584,"['CDKN1A', 'DUSP10', 'BCL6', 'S100A6', 'CD14', 'HIF1A']",0.5688035374703755,0,0,6
88,Leptin Insulin Overlap WP3935,0.1359172106428751,3.6425748164878597,7.26952052419419,"['INSR', 'STAT3']",0.5688035374703755,0,0,2
89,miRNAs involved in DNA damage response WP1545,0.1359172106428751,3.6425748164878597,7.26952052419419,"['CDKN1A', 'CCND3']",0.5688035374703755,0,0,2
90,Peptide GPCRs WP24,0.1359172106428751,3.6425748164878597,7.26952052419419,"['CX3CR1', 'C5AR1']",0.5688035374703755,0,0,2
91,Phytochemical activity on NRF2 transcriptional activation WP3,0.1359172106428751,3.6425748164878597,7.26952052419419,"['CEBPB', 'HMOX1']",0.5688035374703755,0,0,2
92,Fatty acid beta-oxidation WP143,0.13928682030113612,2.5516831683168317,5.029928937018539,"['TPI1', 'GK', 'ACSL1']",0.5688035374703755,0,0,3
93,IL17 signaling pathway WP2112,0.13928682030113612,2.5516831683168317,5.029928937018539,"['CEBPB', 'CEBPD', 'STAT3']",0.5688035374703755,0,0,3
94,Blood Clotting Cascade WP272,0.1405425079844867,12.735700197238659,24.99056770185089,['PLAT'],0.5688035374703755,0,0,1
95,Dopaminergic Neurogenesis WP2855,0.1405425079844867,12.735700197238659,24.99056770185089,['STAT3'],0.5688035374703755,0,0,1
96,Hfe effect on hepcidin production WP3924,0.1405425079844867,12.735700197238659,24.99056770185089,['HAMP'],0.5688035374703755,0,0,1
97,Osteoblast Signaling WP322,0.1405425079844867,12.735700197238659,24.99056770185089,['PDGFB'],0.5688035374703755,0,0,1
98,Thyroxine (Thyroid Hormone) Production WP1981,0.1405425079844867,12.735700197238659,24.99056770185089,['TG'],0.5688035374703755,0,0,1
99,Ferroptosis WP4313,0.14323614044598348,2.127645502645503,4.134569843889706,"['MAP1LC3A', 'ACSL1', 'FTH1', 'HMOX1']",0.5688035374703755,0,0,4
100,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.14365343486928916,1.624126984126984,3.151377363776247,"['RYR2', 'SNAP25', 'CEBPB', 'BHLHE40', 'RORA', 'HIF1A', 'HSP90B1', 'YWHAH']",0.5688035374703755,0,0,8
101,TYROBP causal network in microglia WP3945,0.14398285033711258,1.783100157509497,3.4557570194710934,"['IGSF6', 'DPYD', 'ITGAX', 'TCIRG1', 'SLC1A5', 'GAL3ST4']",0.5688035374703755,0,0,6
102,7q11.23 copy number variation syndrome WP4932,0.15394469866400523,1.6569823316330303,3.1004821095740174,"['GRIP1', 'SNAP25', 'ATP5MC3', 'DDX21', 'NRG1', 'ATP5F1E', 'ATP5MC1']",0.5931482569390836,0,0,7
103,Apoptosis Modulation by HSP70 WP384,0.1620379950034088,3.1867588932806323,5.799660375757498,"['CYCS', 'HSPA1A']",0.5931482569390836,0,0,2
104,Cardiac Progenitor Differentiation WP2406,0.1620379950034088,3.1867588932806323,5.799660375757498,"['NRG1', 'IGF1']",0.5931482569390836,0,0,2
105,Development of ureteric collection system WP5053,0.1620379950034088,3.1867588932806323,5.799660375757498,"['ROBO2', 'GRIP1']",0.5931482569390836,0,0,2
106,Iron metabolism in placenta WP2007,0.1620379950034088,3.1867588932806323,5.799660375757498,"['FTH1', 'HAMP']",0.5931482569390836,0,0,2
107,Nucleotide metabolism WP404,0.1620379950034088,3.1867588932806323,5.799660375757498,"['OAZ1', 'SRM']",0.5931482569390836,0,0,2
108,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.1620379950034088,3.1867588932806323,5.799660375757498,"['OAS1', 'TMEM173']",0.5931482569390836,0,0,2
109,Vitamin B12 metabolism WP1533,0.1620379950034088,3.1867588932806323,5.799660375757498,"['INSR', 'PLAT']",0.5931482569390836,0,0,2
110,IL-18 signaling pathway WP4754,0.1846954863891166,1.3833914559721012,2.336612952806277,"['CEBPB', 'NRN1', 'CD83', 'GRM7', 'TMSB4X', 'TNFAIP2', 'HMOX1', 'CYCS', 'KIFC3', 'RPS11', 'PLA2G7', 'GRIN2B']",0.655573884736995,0,0,12
111,Oncostatin M Signaling Pathway WP2374,0.18859306197379297,1.7250550749556715,2.8776742504159363,"['CEBPB', 'PXN', 'STAT3', 'JAK3', 'HIF1A']",0.655573884736995,0,0,5
112,Pathogenic Escherichia coli infection WP2272,0.18859306197379297,1.7250550749556715,2.8776742504159363,"['LY96', 'CD14', 'TLR5', 'TLR4', 'ACTG1']",0.655573884736995,0,0,5
113,Angiogenesis WP1539,0.18894986652820656,2.8322353974527887,4.7192789459354305,"['PDGFB', 'HIF1A']",0.655573884736995,0,0,2
114,Pre-implantation embryo WP3527,0.18894986652820656,2.8322353974527887,4.7192789459354305,"['ESRRA', 'ZFP36']",0.655573884736995,0,0,2
115,Type II diabetes mellitus WP1584,0.18894986652820656,2.8322353974527887,4.7192789459354305,"['GK', 'INSR']",0.655573884736995,0,0,2
116,Melatonin metabolism and effects WP3298,0.1941327520594925,2.1254125412541254,3.4840040060776056,"['PER3', 'CALM2', 'ARNTL']",0.6592807131741105,0,0,3
117,Cellular Proteostasis WP4918,0.20323691157998894,6.366863905325443,10.14485225354305,['PFDN5'],0.6592807131741105,0,0,1
118,EV release from cardiac cells and their functional effects WP3297,0.20323691157998894,6.366863905325443,10.14485225354305,['CXCL12'],0.6592807131741105,0,0,1
119,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.20323691157998894,6.366863905325443,10.14485225354305,['CEBPB'],0.6592807131741105,0,0,1
120,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.20323691157998894,6.366863905325443,10.14485225354305,['STAT3'],0.6592807131741105,0,0,1
121,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.20323691157998894,6.366863905325443,10.14485225354305,['HIF1A'],0.6592807131741105,0,0,1
122,miR-517 relationship with ARCN1 and USP1 WP3596,0.20323691157998894,6.366863905325443,10.14485225354305,['CDKN1A'],0.6592807131741105,0,0,1
123,Sulfation Biotransformation Reaction WP692,0.20323691157998894,6.366863905325443,10.14485225354305,['SULT4A1'],0.6592807131741105,0,0,1
124,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.21346904009351764,2.01323606044815,3.108966900812022,"['CASP1', 'NLRP3', 'NLRP1']",0.6621353932964253,0,0,3
125,Prion disease pathway WP3995,0.21346904009351764,2.01323606044815,3.108966900812022,"['HSPA5', 'STAT3', 'HSP90B1']",0.6621353932964253,0,0,3
126,Type 2 papillary renal cell carcinoma WP4241,0.21346904009351764,2.01323606044815,3.108966900812022,"['CDKN1A', 'PDGFB', 'HIF1A']",0.6621353932964253,0,0,3
127,MECP2 and Associated Rett Syndrome WP3584,0.21489873733464196,1.6360809501962583,2.5156190102262643,"['RBFOX1', 'CEBPD', 'BCL6', 'IGF1', 'FKBP5']",0.6621353932964253,0,0,5
128,Purinergic signaling WP4900,0.21639920411468946,2.5486166007905138,3.900990072243903,"['P2RY12', 'P2RY13']",0.6621353932964253,0,0,2
129,Statin inhibition of cholesterol production WP430,0.21639920411468946,2.5486166007905138,3.900990072243903,"['APOC1', 'PLTP']",0.6621353932964253,0,0,2
130,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.21639920411468946,2.5486166007905138,3.900990072243903,"['P4HA1', 'P3H2']",0.6621353932964253,0,0,2
131,Pyrimidine metabolism WP4022,0.2173928233629868,1.7594417077175697,2.684994814691753,"['NT5C', 'DPYD', 'ENPP1', 'TYMP']",0.6621353932964253,0,0,4
132,Senescence and Autophagy in Cancer WP615,0.22173820430381547,1.531792828685259,2.3072749771873227,"['GABARAPL1', 'CDKN1A', 'CEBPB', 'MAP1LC3A', 'PLAT', 'IGF1']",0.670254117554715,0,0,6
133,Ectoderm Differentiation WP2858,0.22513376554195808,1.465233467491247,2.184751805133245,"['PLCXD3', 'ZBTB16', 'PIM1', 'SORCS1', 'LDB2', 'KIFC3', 'CDH8']",0.6754012966258742,0,0,7
134,ESC Pluripotency Pathways WP3931,0.2284644765315713,1.5949304174950298,2.3547146686231395,"['FGF14', 'WNT5A', 'STAT3', 'PDGFB', 'MAP2K6']",0.6802785532544549,0,0,5
135,MAPK Signaling Pathway WP382,0.2380049246351287,1.2998906506287589,1.8659461208382324,"['RPS6KA5', 'FGF14', 'DUSP10', 'LRRK2', 'PDGFB', 'CACNA1B', 'MAP3K8', 'CD14', 'HSPA1B', 'HSPA1A', 'RASGRP3', 'MAP2K6']",0.6860866056606052,0,0,12
136,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.2441650431526185,2.3165648580668345,3.2661499883140586,"['BCL6', 'H2AFZ']",0.6860866056606052,0,0,2
137,Folate Metabolism WP176,0.2441650431526185,2.3165648580668345,3.2661499883140586,"['INSR', 'PLAT']",0.6860866056606052,0,0,2
138,IL-9 signaling pathway WP22,0.2441650431526185,2.3165648580668345,3.2661499883140586,"['STAT3', 'JAK3']",0.6860866056606052,0,0,2
139,SARS coronavirus and innate immunity WP4912,0.2441650431526185,2.3165648580668345,3.2661499883140586,"['IFNAR2', 'IKBKE']",0.6860866056606052,0,0,2
140,IL-4 signaling pathway WP395,0.24953955438775843,1.6454173067076292,2.28406602888749,"['CEBPB', 'IL4R', 'STAT3', 'JAK3']",0.6860866056606052,0,0,4
141,Disruption of postsynaptic signaling by CNV WP4875,0.2532223854597283,1.820933521923621,2.501028852422062,"['RYR2', 'DLGAP1', 'GRIN2B']",0.6860866056606052,0,0,3
142,Glycogen Synthesis and Degradation WP500,0.2532223854597283,1.820933521923621,2.501028852422062,"['CALM3', 'PYGL', 'CALM2']",0.6860866056606052,0,0,3
143,Hepatitis C and Hepatocellular Carcinoma WP3646,0.2532223854597283,1.820933521923621,2.501028852422062,"['CDKN1A', 'STAT3', 'HIF1A']",0.6860866056606052,0,0,3
144,PPAR signaling pathway WP3942,0.2532223854597283,1.820933521923621,2.501028852422062,"['ACSL1', 'OLR1', 'PLTP']",0.6860866056606052,0,0,3
145,Alzheimer's disease WP2059,0.2562944830006751,1.5185079996213198,2.0673395691763896,"['ATP5MD', 'CYCS', 'CALM3', 'GRIN2B', 'CALM2']",0.6860866056606052,0,0,5
146,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.2562944830006751,1.5185079996213198,2.0673395691763896,"['HSPA5', 'CASP1', 'STUB1', 'HSPA1B', 'HSPA1A']",0.6860866056606052,0,0,5
147,Farnesoid X receptor pathway WP2879,0.26136632596594483,4.243918474687706,5.694626921640552,['FKBP5'],0.6860866056606052,0,0,1
148,"GPCRs, Class B Secretin-like WP334",0.26136632596594483,4.243918474687706,5.694626921640552,['ADGRE2'],0.6860866056606052,0,0,1
149,Inflammatory Response Pathway WP453,0.26136632596594483,4.243918474687706,5.694626921640552,['IL4R'],0.6860866056606052,0,0,1
150,PTF1A related regulatory pathway WP4147,0.26136632596594483,4.243918474687706,5.694626921640552,['RBPJ'],0.6860866056606052,0,0,1
151,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.26136632596594483,4.243918474687706,5.694626921640552,['STAT3'],0.6860866056606052,0,0,1
152,Thiamine metabolic pathways WP4297,0.26136632596594483,4.243918474687706,5.694626921640552,['SLC25A19'],0.6860866056606052,0,0,1
153,Myometrial relaxation and contraction pathways WP289,0.2678683448536017,1.343578947368421,1.7698423604541098,"['RGS4', 'RYR2', 'GNG3', 'PDE4B', 'CALM3', 'CALM2', 'ACTG1', 'YWHAH']",0.6940225298479681,0,0,8
154,Regulation of Actin Cytoskeleton WP51,0.2678683448536017,1.343578947368421,1.7698423604541098,"['CHRM3', 'FGF14', 'TMSB4X', 'PXN', 'PDGFB', 'IQGAP1', 'CD14', 'ACTG1']",0.6940225298479681,0,0,8
155,Pathways Regulating Hippo Signaling WP4540,0.2705075549472806,1.4829626889823848,1.938907355519449,"['PRKD3', 'INSR', 'CDH12', 'CDH8', 'CDH18']",0.695834710115007,0,0,5
156,Prostaglandin Synthesis and Regulation WP98,0.2720556761351907,2.1231884057971016,2.7638574115509,"['HPGDS', 'S100A6']",0.695834710115007,0,0,2
157,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.2826088019769506,1.5452140452140453,1.9526741061807633,"['RPS6KA5', 'IRAK2', 'MAP3K8', 'MAP2K6']",0.7174554982890613,0,0,4
158,Androgen receptor signaling pathway WP138,0.28410518478614455,1.3914523723288663,1.7510186101288927,"['CDKN1A', 'LIMK2', 'STAT3', 'DSTN', 'STUB1', 'CALR']",0.7174554982890613,0,0,6
159,Phosphodiesterases in neuronal function WP4222,0.29390518285242306,1.6620749031424882,2.03520751269699,"['PDE4B', 'PDE5A', 'GRIN2B']",0.7211256539416805,0,0,3
160,Retinoblastoma gene in cancer WP2446,0.29938952064392765,1.4995331465919701,1.8084516834083222,"['CDKN1A', 'CCND3', 'H2AFZ', 'SAP30']",0.7211256539416805,0,0,4
161,Nuclear receptors WP170,0.29990557397007,1.9595621769534812,2.3598764454473025,"['ESRRA', 'RORA']",0.7211256539416805,0,0,2
162,SARS-CoV-2 mitochondrial interactions WP5038,0.29990557397007,1.9595621769534812,2.3598764454473025,"['TMEM173', 'IKBKE']",0.7211256539416805,0,0,2
163,DNA damage response (only ATM dependent) WP710,0.3100805738120069,1.3422101069406585,1.5716248189381306,"['CCND3', 'CDKN1A', 'MLKL', 'BCL6', 'INSR', 'WNT5A']",0.7211256539416805,0,0,6
164,Hippo-Merlin Signaling Dysregulation WP4541,0.31403478487534475,1.385599446797476,1.6048726644660973,"['INSR', 'ITGAX', 'CDH12', 'CDH8', 'CDH18']",0.7211256539416805,0,0,5
165,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.31441830472759025,1.5925742574257427,1.8426577840161698,"['XBP1', 'MAP1LC3A', 'HSPA5']",0.7211256539416805,0,0,3
166,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.31441830472759025,1.5925742574257427,1.8426577840161698,"['IFNAR2', 'OAS1', 'IKBKE']",0.7211256539416805,0,0,3
167,Cell Differentiation - Index WP2029,0.3152625311622363,3.1824457593688362,3.673654846162138,['STAT3'],0.7211256539416805,0,0,1
168,Cells and molecules involved in local acute inflammatory response  WP4493,0.3152625311622363,3.1824457593688362,3.673654846162138,['SELPLG'],0.7211256539416805,0,0,1
169,GDNF/RET signaling axis WP4830,0.3152625311622363,3.1824457593688362,3.673654846162138,['ROBO2'],0.7211256539416805,0,0,1
170,Hedgehog Signaling Pathway Netpath WP47,0.3152625311622363,3.1824457593688362,3.673654846162138,['ARNTL'],0.7211256539416805,0,0,1
171,NAD+ metabolism WP3644,0.3152625311622363,3.1824457593688362,3.673654846162138,['NAMPT'],0.7211256539416805,0,0,1
172,NOTCH1 regulation of endothelial cell calcification WP3413,0.3152625311622363,3.1824457593688362,3.673654846162138,['PLAT'],0.7211256539416805,0,0,1
173,Tryptophan catabolism leading to NAD+ production WP4210,0.3152625311622363,3.1824457593688362,3.673654846162138,['NAMPT'],0.7211256539416805,0,0,1
174,3q29 copy number variation syndrome WP4906,0.31628318155336865,1.4564625850340136,1.6765593112588564,"['PXN', 'DYNLL1', 'HIF1A', 'HAMP']",0.7211256539416805,0,0,4
175,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.31628318155336865,1.4564625850340136,1.6765593112588564,"['EIF4A2', 'RPS6KA5', 'PIM1', 'MAP2K6']",0.7211256539416805,0,0,4
176,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.32757259962140917,1.8193111236589496,2.0304341204488536,"['PTPN1', 'CEBPB']",0.7426219730053537,0,0,2
177,Apoptosis WP254,0.35026385466560106,1.3773058773058773,1.4448882631435067,"['CASP4', 'CASP1', 'CYCS', 'IGF1']",0.7632575511605197,0,0,4
178,Physiological and pathological hypertrophy of the heart WP1528,0.35493548734096575,1.697760210803689,1.758572677370854,"['STAT3', 'CALM2']",0.7632575511605197,0,0,2
179,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.3554719550272175,1.4696115765422697,1.5200323649969776,"['CDKN1A', 'CEBPB', 'CEBPD']",0.7632575511605197,0,0,3
180,Hepatitis B infection WP4666,0.3559276114113134,1.2140952380952381,1.254194263361975,"['CDKN1A', 'STAT3', 'CYCS', 'IKBKE', 'JAK3', 'TLR4', 'MAP2K6', 'TLR2']",0.7632575511605197,0,0,8
181,VEGFA-VEGFR2 Signaling Pathway WP3888,0.3625010142777802,1.1056673471371634,1.121951623215696,"['HDAC4', 'PTPN1', 'STAT3', 'PXN', 'HTRA1', 'IQGAP1', 'LDB2', 'RPL10A', 'SLC7A1', 'PTPN14', 'RPL7', 'ACTG1', 'RPS6KA5', 'TMSB4X', 'TXNIP', 'CYCS', 'RPL26', 'CALR', 'RPS11', 'TMSB10', 'HSPA1A', 'MAP2K6']",0.7632575511605197,0,0,22
182,Cytokines and Inflammatory Response WP530,0.36523324036459376,2.545562130177515,2.563938835387828,['IL15'],0.7632575511605197,0,0,1
183,Fatty acid transporters WP5061,0.36523324036459376,2.545562130177515,2.563938835387828,['ACSL1'],0.7632575511605197,0,0,1
184,FOXP3 in COVID-19 WP5063,0.36523324036459376,2.545562130177515,2.563938835387828,['STAT3'],0.7632575511605197,0,0,1
185,Glial Cell Differentiation WP2276,0.36523324036459376,2.545562130177515,2.563938835387828,['GAP43'],0.7632575511605197,0,0,1
186,LDLRAD4 and what we know about it WP4904,0.36523324036459376,2.545562130177515,2.563938835387828,['PMEPA1'],0.7632575511605197,0,0,1
187,Osteoclast Signaling WP12,0.36523324036459376,2.545562130177515,2.563938835387828,['PDGFB'],0.7632575511605197,0,0,1
188,Selective expression of chemokine receptors during T-cell polarization WP4494,0.36523324036459376,2.545562130177515,2.563938835387828,['IL4R'],0.7632575511605197,0,0,1
189,Urea cycle and metabolism of amino groups WP497,0.36523324036459376,2.545562130177515,2.563938835387828,['SRM'],0.7632575511605197,0,0,1
190,Vitamin A and carotenoid metabolism WP716,0.36523324036459376,2.545562130177515,2.563938835387828,['BCO2'],0.7632575511605197,0,0,1
191,AGE/RAGE pathway WP2324,0.36728182912987417,1.3408521303258145,1.3430320861747396,"['INSR', 'STAT3', 'CYCS', 'HIF1A']",0.7632575511605197,0,0,4
192,Interferon type I signaling pathways WP585,0.36728182912987417,1.3408521303258145,1.3430320861747396,"['IFNAR2', 'RPS6KA5', 'STAT3', 'MAP2K6']",0.7632575511605197,0,0,4
193,Common Pathways Underlying Drug Addiction WP2636,0.3758993138518054,1.4149614961496149,1.3844463710977502,"['GRM5', 'CALM2', 'ACTG1']",0.7706591353579034,0,0,3
194,Insulin Signaling WP481,0.3785493036972668,1.17050427385383,1.1370383321165682,"['SNAP25', 'PTPN1', 'XBP1', 'RPS6KA5', 'TBC1D4', 'INSR', 'ENPP1', 'MAP3K8', 'MAP2K6']",0.7706591353579034,0,0,9
195,IL-7 signaling pathway WP205,0.38189156432779525,1.591403162055336,1.5319142420211347,"['STAT3', 'JAK3']",0.7706591353579034,0,0,2
196,TLR4 Signaling and Tolerance WP3851,0.38189156432779525,1.591403162055336,1.5319142420211347,"['IKBKE', 'TLR4']",0.7706591353579034,0,0,2
197,Cytosolic DNA-sensing pathway WP4655,0.3961922489782261,1.3642149929278642,1.2630662385723326,"['CASP1', 'TMEM173', 'IKBKE']",0.7706591353579034,0,0,3
198,Apoptosis Modulation and Signaling WP1772,0.40121245362587316,1.2734126984126983,1.162962206917277,"['CASP4', 'CASP1', 'CYCS', 'HSPA1A']",0.7706591353579034,0,0,4
199,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.40121245362587316,1.2734126984126983,1.162962206917277,"['NHSL1', 'TG', 'TBC1D4', 'MGLL']",0.7706591353579034,0,0,4
200,Nanoparticle triggered autophagic cell death WP2509,0.40835469250472656,1.4975587072773773,1.341242238313395,"['MAP1LC3A', 'INSR']",0.7706591353579034,0,0,2
201,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.40835469250472656,1.4975587072773773,1.341242238313395,"['ANGPT2', 'HIF1A']",0.7706591353579034,0,0,2
202,Signal transduction through IL1R WP4496,0.40835469250472656,1.4975587072773773,1.341242238313395,"['IRAK2', 'MAP2K6']",0.7706591353579034,0,0,2
203,The influence of laminopathies on Wnt signaling WP4844,0.40835469250472656,1.4975587072773773,1.341242238313395,"['CEBPB', 'CEBPD']",0.7706591353579034,0,0,2
204,Cell Differentiation - Index expanded WP2023,0.4115638408069491,2.120973044049967,1.8829810537895557,['STAT3'],0.7706591353579034,0,0,1
205,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.4115638408069491,2.120973044049967,1.8829810537895557,['STAT3'],0.7706591353579034,0,0,1
206,Dual hijack model of Vif in HIV infection WP3300,0.4115638408069491,2.120973044049967,1.8829810537895557,['RUNX1'],0.7706591353579034,0,0,1
207,Estrogen Receptor Pathway WP2881,0.4115638408069491,2.120973044049967,1.8829810537895557,['STAT3'],0.7706591353579034,0,0,1
208,Galanin receptor pathway WP4970,0.4115638408069491,2.120973044049967,1.8829810537895557,['CDKN1A'],0.7706591353579034,0,0,1
209,Nanomaterial induced apoptosis WP2507,0.4115638408069491,2.120973044049967,1.8829810537895557,['CYCS'],0.7706591353579034,0,0,1
210,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4115638408069491,2.120973044049967,1.8829810537895557,['ANAPC11'],0.7706591353579034,0,0,1
211,Metapathway biotransformation Phase I and II WP702,0.41630507375267306,1.3169682485489929,1.154107921222796,"['SULT4A1', 'HS3ST4', 'GAL3ST4']",0.7706591353579034,0,0,3
212,Ras signaling WP4223,0.42398569037260586,1.132088888888889,0.9713951807416341,"['GNG10', 'GNG3', 'INSR', 'CALM3', 'KSR2', 'GRIN2B', 'CALM2', 'RASGRP3']",0.7706591353579034,0,0,8
213,G Protein Signaling Pathways WP35,0.4324304541932209,1.178852809071497,0.9882721139194662,"['GNG10', 'GNG3', 'PRKD3', 'PDE4B', 'CALM2']",0.7706591353579034,0,0,5
214,Glycerophospholipid Biosynthetic Pathway WP2533,0.43425341083002034,1.4141414141414141,1.1795735627326176,"['PGS1', 'GK']",0.7706591353579034,0,0,2
215,Parkinson's disease pathway WP2371,0.43425341083002034,1.4141414141414141,1.1795735627326176,"['LRRK2', 'CYCS']",0.7706591353579034,0,0,2
216,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.43425341083002034,1.4141414141414141,1.1795735627326176,"['CALM3', 'CALM2']",0.7706591353579034,0,0,2
217,Non-small cell lung cancer WP4255,0.43480821971384703,1.2123960695389266,1.0097443324280304,"['CDKN1A', 'STAT3', 'CYCS', 'JAK3']",0.7706591353579034,0,0,4
218,DNA damage response WP707,0.43619629182225156,1.272871287128713,1.0560541169409996,"['CDKN1A', 'CCND3', 'CYCS']",0.7706591353579034,0,0,3
219,G13 Signaling Pathway WP524,0.43619629182225156,1.272871287128713,1.0560541169409996,"['IQGAP1', 'IQGAP2', 'CALM2']",0.7706591353579034,0,0,3
220,miRNA regulation of DNA damage response WP1530,0.43619629182225156,1.272871287128713,1.0560541169409996,"['CDKN1A', 'CCND3', 'CYCS']",0.7706591353579034,0,0,3
221,Chemokine signaling pathway WP3929,0.43903800425664685,1.128199297607317,0.9286990256129983,"['CX3CR1', 'GNG10', 'GNG3', 'CXCL12', 'PXN', 'STAT3', 'JAK3']",0.7706591353579034,0,0,7
222,Base Excision Repair WP4752,0.4545190101442091,1.8176951253874332,1.433280852876543,['APEX1'],0.7706591353579034,0,0,1
223,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.4545190101442091,1.8176951253874332,1.433280852876543,['RYR2'],0.7706591353579034,0,0,1
224,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.4545190101442091,1.8176951253874332,1.433280852876543,['RAB27A'],0.7706591353579034,0,0,1
225,ERK Pathway in Huntington's Disease WP3853,0.4545190101442091,1.8176951253874332,1.433280852876543,['RPS6KA5'],0.7706591353579034,0,0,1
226,Globo Sphingolipid Metabolism WP1424,0.4545190101442091,1.8176951253874332,1.433280852876543,['ST6GALNAC5'],0.7706591353579034,0,0,1
227,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.4545190101442091,1.8176951253874332,1.433280852876543,['UGCG'],0.7706591353579034,0,0,1
228,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.4545190101442091,1.8176951253874332,1.433280852876543,['ACSL1'],0.7706591353579034,0,0,1
229,NAD+ biosynthetic pathways WP3645,0.4545190101442091,1.8176951253874332,1.433280852876543,['NAMPT'],0.7706591353579034,0,0,1
230,Neuroinflammation WP4919,0.4545190101442091,1.8176951253874332,1.433280852876543,['TLR4'],0.7706591353579034,0,0,1
231,Omega-3/Omega-6 FA synthesis WP4723,0.4545190101442091,1.8176951253874332,1.433280852876543,['ACSL1'],0.7706591353579034,0,0,1
232,Ovarian infertility WP34,0.4545190101442091,1.8176951253874332,1.433280852876543,['CEBPB'],0.7706591353579034,0,0,1
233,Proteoglycan biosynthesis WP4784,0.4545190101442091,1.8176951253874332,1.433280852876543,['CSGALNACT1'],0.7706591353579034,0,0,1
234,RalA downstream regulated genes WP2290,0.4545190101442091,1.8176951253874332,1.433280852876543,['YBX3'],0.7706591353579034,0,0,1
235,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.4545190101442091,1.8176951253874332,1.433280852876543,['STAT3'],0.7706591353579034,0,0,1
236,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.4558284610136973,1.2316192909613541,0.9676078060240203,"['CXCL12', 'TMEM173', 'IKBKE']",0.7706591353579034,0,0,3
237,Pathways in clear cell renal cell carcinoma WP4018,0.46786018944512114,1.156926406926407,0.8787848335539793,"['TPI1', 'STAT3', 'PDGFB', 'HIF1A']",0.7876633569139382,0,0,4
238,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.47516803781053646,1.1929455445544555,0.8876550014419504,"['ANGPT2', 'PXN', 'STAT3']",0.788013295852617,0,0,3
239,Hematopoietic Stem Cell Differentiation WP2849,0.48413527032126696,1.2723320158102767,0.9229381006282338,"['PIM1', 'RUNX1']",0.788013295852617,0,0,2
240,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.49418520765239926,1.1566156615661567,0.8152346708806976,"['CDKN1A', 'TMSB4X', 'PFN2']",0.788013295852617,0,0,3
241,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.49418520765239926,1.1566156615661567,0.8152346708806976,"['IFI27L2', 'TLR4', 'TLR2']",0.788013295852617,0,0,3
242,Computational Model of Aerobic Glycolysis WP4629,0.4943442163788566,1.5902366863905326,1.1203586551996607,['TPI1'],0.788013295852617,0,0,1
243,Omega-9 FA synthesis WP4724,0.4943442163788566,1.5902366863905326,1.1203586551996607,['ACSL1'],0.788013295852617,0,0,1
244,PPAR-alpha pathway WP2878,0.4943442163788566,1.5902366863905326,1.1203586551996607,['PLTP'],0.788013295852617,0,0,1
245,Purine metabolism and related disorders WP4224,0.4943442163788566,1.5902366863905326,1.1203586551996607,['GRM5'],0.788013295852617,0,0,1
246,TP53 network WP1742,0.4943442163788566,1.5902366863905326,1.1203586551996607,['CDKN1A'],0.788013295852617,0,0,1
247,Triacylglyceride synthesis WP325,0.4943442163788566,1.5902366863905326,1.1203586551996607,['GK'],0.788013295852617,0,0,1
248,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5001873780912313,1.106280193236715,0.7664004891741962,"['STAT3', 'PDGFB', 'NRG1', 'IGF1']",0.788013295852617,0,0,4
249,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5001873780912313,1.106280193236715,0.7664004891741962,"['CCND3', 'APEX1', 'STAT3', 'MAP2K6']",0.788013295852617,0,0,4
250,Aryl Hydrocarbon Receptor Netpath WP2586,0.5080346068410794,1.2115565593826463,0.820473020027394,"['CDKN1A', 'HPGDS']",0.788013295852617,0,0,2
251,Integrated Cancer Pathway WP1971,0.5080346068410794,1.2115565593826463,0.820473020027394,"['CDKN1A', 'BACH1']",0.788013295852617,0,0,2
252,Neural Crest Differentiation WP2064,0.5080346068410794,1.2115565593826463,0.820473020027394,"['HDAC4', 'RBPJ']",0.788013295852617,0,0,2
253,Vitamin D-sensitive calcium signaling in depression WP4698,0.5080346068410794,1.2115565593826463,0.820473020027394,"['GRM5', 'GRIN2B']",0.788013295852617,0,0,2
254,Exercise-induced Circadian Regulation WP410,0.5128537047098563,1.122422830518346,0.7495142891185399,"['CEBPB', 'ERC2', 'ARNTL']",0.788013295852617,0,0,3
255,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.531199341412464,1.156306144448437,0.7314999887144605,"['CCND3', 'WNT5A']",0.788013295852617,0,0,2
256,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.531199341412464,1.156306144448437,0.7314999887144605,"['CDKN1A', 'MAP2K6']",0.788013295852617,0,0,2
257,Airway smooth muscle cell contraction WP4962,0.5312671092339699,1.413324567170721,0.8939141553052807,['CALM2'],0.788013295852617,0,0,1
258,Autosomal recessive Osteopetrosis pathways WP4788,0.5312671092339699,1.413324567170721,0.8939141553052807,['TCIRG1'],0.788013295852617,0,0,1
259,Cancer immunotherapy by PD-1 blockade WP4585,0.5312671092339699,1.413324567170721,0.8939141553052807,['STAT3'],0.788013295852617,0,0,1
260,Canonical and non-canonical Notch signaling WP3845,0.5312671092339699,1.413324567170721,0.8939141553052807,['RBPJ'],0.788013295852617,0,0,1
261,Eicosanoid Synthesis WP167,0.5312671092339699,1.413324567170721,0.8939141553052807,['LTC4S'],0.788013295852617,0,0,1
262,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.5312671092339699,1.413324567170721,0.8939141553052807,['WNT5A'],0.788013295852617,0,0,1
263,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.5312671092339699,1.413324567170721,0.8939141553052807,['MAP2K6'],0.788013295852617,0,0,1
264,Methionine De Novo and Salvage Pathway WP3580,0.5312671092339699,1.413324567170721,0.8939141553052807,['SRM'],0.788013295852617,0,0,1
265,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.5312671092339699,1.413324567170721,0.8939141553052807,['HMOX1'],0.788013295852617,0,0,1
266,Sleep regulation WP3591,0.5312671092339699,1.413324567170721,0.8939141553052807,['PER3'],0.788013295852617,0,0,1
267,Striated Muscle Contraction Pathway WP383,0.5312671092339699,1.413324567170721,0.8939141553052807,['ACTG1'],0.788013295852617,0,0,1
268,Wnt signaling in kidney disease WP4150,0.5312671092339699,1.413324567170721,0.8939141553052807,['WNT5A'],0.788013295852617,0,0,1
269,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.5312671092339699,1.413324567170721,0.8939141553052807,['ZBTB16'],0.788013295852617,0,0,1
270,Synaptic Vesicle Pathway WP2267,0.5490562349316678,1.0597359735973597,0.6353693776234067,"['SNAP25', 'CACNA1B', 'SYN3']",0.8032368476893638,0,0,3
271,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5536093561768798,1.10586011342155,0.6538906331088558,"['MAP1LC3A', 'IGF1']",0.8032368476893638,0,0,2
272,G1 to S cell cycle control WP45,0.5536093561768798,1.10586011342155,0.6538906331088558,"['CDKN1A', 'CCND3']",0.8032368476893638,0,0,2
273,Glycolysis and Gluconeogenesis WP534,0.5536093561768798,1.10586011342155,0.6538906331088558,"['TPI1', 'PGAM1']",0.8032368476893638,0,0,2
274,Metabolic reprogramming in colon cancer WP4290,0.5536093561768798,1.10586011342155,0.6538906331088558,"['PGAM1', 'SLC1A5']",0.8032368476893638,0,0,2
275,p38 MAPK Signaling Pathway WP400,0.5536093561768798,1.10586011342155,0.6538906331088558,"['RPS6KA5', 'MAP2K6']",0.8032368476893638,0,0,2
276,Imatinib and Chronic Myeloid Leukemia WP3640,0.5654988115908909,1.2717948717948717,0.7249829593176843,['PIM1'],0.8145632701255071,0,0,1
277,Mitochondrial Gene Expression WP391,0.5654988115908909,1.2717948717948717,0.7249829593176843,['ESRRA'],0.8145632701255071,0,0,1
278,Amyotrophic lateral sclerosis (ALS) WP2447,0.5752513564393383,1.0596179183135706,0.5859138122161721,"['CASP1', 'MAP2K6']",0.8220697055512534,0,0,2
279,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5752513564393383,1.0596179183135706,0.5859138122161721,"['CYCS', 'ACTG1']",0.8220697055512534,0,0,2
280,Cell cycle WP179,0.576891021439476,0.9970432617491441,0.5484753939677395,"['CCND3', 'CDKN1A', 'ANAPC11', 'YWHAH']",0.8220697055512534,0,0,4
281,Melanoma WP4685,0.5836292885203077,1.003647733194372,0.5404535428558432,"['CDKN1A', 'CALM3', 'CALM2']",0.8257733550340525,0,0,3
282,MET in type 1 papillary renal cell carcinoma WP4205,0.5836292885203077,1.003647733194372,0.5404535428558432,"['CDKN1A', 'STAT3', 'JAK3']",0.8257733550340525,0,0,3
283,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.5972351165451711,1.1559978483055406,0.5958526324200031,['MAP2K6'],0.8274194843802892,0,0,1
284,Endothelin Pathways WP2197,0.5972351165451711,1.1559978483055406,0.5958526324200031,['CALM2'],0.8274194843802892,0,0,1
285,Fatty Acid Biosynthesis WP357,0.5972351165451711,1.1559978483055406,0.5958526324200031,['ACSL1'],0.8274194843802892,0,0,1
286,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.5972351165451711,1.1559978483055406,0.5958526324200031,['CDKN1A'],0.8274194843802892,0,0,1
287,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5972351165451711,1.1559978483055406,0.5958526324200031,['HIF1A'],0.8274194843802892,0,0,1
288,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.5972351165451711,1.1559978483055406,0.5958526324200031,['PXN'],0.8274194843802892,0,0,1
289,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.6195623712562959,0.9412110523221634,0.4505971703009301,"['WNT5A', 'RBPJ', 'HIF1A', 'MAP2K6']",0.853366491196047,0,0,4
290,Heart Development WP1591,0.6266575987980997,1.059500328731098,0.4951627569931637,['BHLHE40'],0.853366491196047,0,0,1
291,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6266575987980997,1.059500328731098,0.4951627569931637,['NAMPT'],0.853366491196047,0,0,1
292,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.6266575987980997,1.059500328731098,0.4951627569931637,['RPS6KA5'],0.853366491196047,0,0,1
293,Sphingolipid Metabolism (general overview) WP4725,0.6266575987980997,1.059500328731098,0.4951627569931637,['UGCG'],0.853366491196047,0,0,1
294,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.635520727514051,0.9414434197042892,0.42676625585629285,"['CCND3', 'WNT5A']",0.8556458165822797,0,0,2
295,Signaling of Hepatocyte Growth Factor Receptor WP313,0.635520727514051,0.9414434197042892,0.42676625585629285,"['PXN', 'STAT3']",0.8556458165822797,0,0,2
296,Wnt signaling pathway and pluripotency WP399,0.647518572101901,0.9074964639321075,0.39440504445331465,"['CCND3', 'LRRK2', 'WNT5A']",0.8556458165822797,0,0,3
297,Cell migration and invasion through p75NTR WP4561,0.6539346452911629,0.9778485813988772,0.4153390955466722,['STAT3'],0.8556458165822797,0,0,1
298,Ethanol effects on histone modifications WP3996,0.6539346452911629,0.9778485813988772,0.4153390955466722,['HDAC4'],0.8556458165822797,0,0,1
299,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6539346452911629,0.9778485813988772,0.4153390955466722,['ANGPT2'],0.8556458165822797,0,0,1
300,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.6539346452911629,0.9778485813988772,0.4153390955466722,['RAB27A'],0.8556458165822797,0,0,1
301,MTHFR deficiency WP4288,0.6539346452911629,0.9778485813988772,0.4153390955466722,['CYCS'],0.8556458165822797,0,0,1
302,Sphingolipid Metabolism (integrated pathway) WP4726,0.6539346452911629,0.9778485813988772,0.4153390955466722,['UGCG'],0.8556458165822797,0,0,1
303,Genotoxicity pathway WP4286,0.65406509788871,0.9076792772444946,0.38535377980462593,"['CDKN1A', 'CEBPD']",0.8556458165822797,0,0,2
304,PDGF Pathway WP2526,0.65406509788871,0.9076792772444946,0.38535377980462593,"['STAT3', 'PDGFB']",0.8556458165822797,0,0,2
305,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.65406509788871,0.9076792772444946,0.38535377980462593,"['IFNAR2', 'CXCL12']",0.8556458165822797,0,0,2
306,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.6718494155865902,0.8762436963336514,0.3485005607869284,"['RYR2', 'ACTG1']",0.8731853968047214,0,0,2
307,IL-2 signaling pathway WP49,0.6718494155865902,0.8762436963336514,0.3485005607869284,"['STAT3', 'JAK3']",0.8731853968047214,0,0,2
308,Overview of interferons-mediated signaling pathway WP4558,0.6792224109625283,0.907861369399831,0.3511668135207881,['IFNAR2'],0.8799017596560026,0,0,1
309,Ebola Virus Pathway on Host WP4217,0.6818887364145417,0.8694408889130968,0.3328991590949995,"['SCIN', 'IQGAP1', 'IKBKE', 'TLR4', 'ACTG1']",0.88049710624402,0,0,5
310,TNF-alpha signaling pathway WP231,0.6844001512754346,0.860774818401937,0.32641658453578887,"['MAP3K8', 'PYGL', 'KSR2', 'MAP2K6']",0.8808892269641885,0,0,4
311,Circadian rhythm related genes WP3594,0.7012335408441762,0.8553202918662429,0.30356539717887593,"['PER3', 'NAMPT', 'BHLHE40', 'RORA', 'RPS27A', 'ARNTL']",0.8816465936013483,0,0,6
312,16p11.2 distal deletion syndrome WP4950,0.7026657061785182,0.8472057856673241,0.2989569155142351,['INSR'],0.8816465936013483,0,0,1
313,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7026657061785182,0.8472057856673241,0.2989569155142351,['WNT5A'],0.8816465936013483,0,0,1
314,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.7026657061785182,0.8472057856673241,0.2989569155142351,['MAP1LC3A'],0.8816465936013483,0,0,1
315,miRNAs involvement in the immune response in sepsis WP4329,0.7026657061785182,0.8472057856673241,0.2989569155142351,['TLR4'],0.8816465936013483,0,0,1
316,Oxidative Stress WP408,0.7026657061785182,0.8472057856673241,0.2989569155142351,['HMOX1'],0.8816465936013483,0,0,1
317,Sphingolipid pathway WP1422,0.7026657061785182,0.8472057856673241,0.2989569155142351,['UGCG'],0.8816465936013483,0,0,1
318,Vitamin D in inflammatory diseases WP4482,0.7026657061785182,0.8472057856673241,0.2989569155142351,['MAP2K6'],0.8816465936013483,0,0,1
319,Splicing factor NOVA regulated synaptic proteins WP4148,0.7051882121950488,0.8194568404947087,0.2862285257212467,"['EPB41L3', 'GRIN2B']",0.8820379205825218,0,0,2
320,Intraflagellar transport proteins binding to dynein WP4532,0.724398818879866,0.7941321499013807,0.25603867453350104,['DYNLL1'],0.900420961785254,0,0,1
321,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.724398818879866,0.7941321499013807,0.25603867453350104,['CALM2'],0.900420961785254,0,0,1
322,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.7356583209776769,0.7695532399089712,0.23624476884265952,"['CDKN1A', 'TLR4']",0.9112698312654162,0,0,2
323,Prolactin Signaling Pathway WP2037,0.7418531389160611,0.7770054556476056,0.23201692262109905,"['PTPN1', 'PXN', 'STAT3']",0.9112698312654162,0,0,3
324,Aryl Hydrocarbon Receptor Pathway WP2873,0.744546278176756,0.7473024712843718,0.22043948378987394,['SLC7A5'],0.9112698312654162,0,0,1
325,EPO Receptor Signaling WP581,0.744546278176756,0.7473024712843718,0.22043948378987394,['STAT3'],0.9112698312654162,0,0,1
326,Nanoparticle-mediated activation of receptor signaling WP2643,0.744546278176756,0.7473024712843718,0.22043948378987394,['PXN'],0.9112698312654162,0,0,1
327,AMP-activated protein kinase (AMPK) signaling WP1403,0.7498626035202581,0.7468030690537084,0.21497867796879963,"['CDKN1A', 'INSR']",0.9121804231847043,0,0,2
328,Modulators of TCR signaling and T cell activation WP5072,0.7498626035202581,0.7468030690537084,0.21497867796879963,"['NDUFB10', 'MAP3K8']",0.9121804231847043,0,0,2
329,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7527067206798309,0.7924950298210736,0.22513167758677186,"['PTPN1', 'RPS6KA5', 'INSR', 'MAP3K8', 'MAP2K6']",0.9128570867819227,0,0,5
330,Notch Signaling WP268,0.763223561898435,0.7056760902914749,0.19067670470043452,['RBPJ'],0.9136473324431766,0,0,1
331,Type II interferon signaling (IFNG) WP619,0.763223561898435,0.7056760902914749,0.19067670470043452,['OAS1'],0.9136473324431766,0,0,1
332,Rett syndrome causing genes WP4312,0.7634059506541931,0.7253529079616036,0.19582014714902996,"['CECR2', 'GRIN2B']",0.9136473324431766,0,0,2
333,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.7634059506541931,0.7253529079616036,0.19582014714902996,"['MAP3K8', 'CALM2']",0.9136473324431766,0,0,2
334,Thermogenesis WP4321,0.7648075414436617,0.7463016889924287,0.2001066604263214,"['ACSL1', 'MGLL', 'ACTG1']",0.9136473324431766,0,0,3
335,Translation Factors WP107,0.7763090056009128,0.7050944224857268,0.1785331758626038,"['EIF4A2', 'EEF1B2']",0.9246187857754155,0,0,2
336,ATM Signaling Pathway WP2516,0.7805377536349067,0.6684314336136199,0.16561870620612773,['CDKN1A'],0.9268885824414518,0,0,1
337,Integrin-mediated Cell Adhesion WP185,0.7860772022616468,0.7179151877451896,0.17280237929005146,"['PXN', 'ITGAX', 'MAP2K6']",0.9306967468913859,0,0,3
338,Small cell lung cancer WP4658,0.7885929203016552,0.6859309902788163,0.16291206394427785,"['CDKN1A', 'CYCS']",0.9309129443797645,0,0,2
339,Breast cancer pathway WP4262,0.796101418063909,0.7045104510451045,0.16064859638840817,"['CDKN1A', 'WNT5A', 'IGF1']",0.9370043239159284,0,0,3
340,Focal Adhesion WP306,0.8034830618719719,0.736511165564751,0.16114803500607017,"['CCND3', 'PXN', 'PDGFB', 'IGF1', 'ACTG1']",0.94291100496152,0,0,5
341,Osteoblast differentiation WP4787,0.8113894032099896,0.6505523462045201,0.13597011664361086,"['WNT5A', 'RBPJ']",0.9467113049664264,0,0,2
342,miRNA regulation of prostate cancer signaling pathways WP3981,0.8114668328283654,0.6045834507372969,0.12630459536033964,['CDKN1A'],0.9467113049664264,0,0,1
343,IL-1 signaling pathway WP195,0.8219452846498477,0.6341897233201581,0.12435284041446626,"['IRAK2', 'MAP2K6']",0.9561404331641086,0,0,2
344,MAPK Cascade WP422,0.8380443625887202,0.5518394648829431,0.09750133714532805,['MAP2K6'],0.9608612088301706,0,0,1
345,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8380443625887202,0.5518394648829431,0.09750133714532805,['STAT3'],0.9608612088301706,0,0,1
346,Neural Crest Cell Migration during Development WP4564,0.8380443625887202,0.5518394648829431,0.09750133714532805,['STAT3'],0.9608612088301706,0,0,1
347,PDGFR-beta pathway WP3972,0.8380443625887202,0.5518394648829431,0.09750133714532805,['STAT3'],0.9608612088301706,0,0,1
348,Target Of Rapamycin (TOR) Signaling WP1471,0.8380443625887202,0.5518394648829431,0.09750133714532805,['DDIT4'],0.9608612088301706,0,0,1
349,Kit receptor signaling pathway WP304,0.8414801214611224,0.6038019951063429,0.10421193034142498,"['STAT3', 'SOCS6']",0.9620360127879307,0,0,2
350,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.8505015694296619,0.5896681680301499,0.09548438966258406,"['CDKN1A', 'CYCS']",0.965430076284764,0,0,2
351,Male infertility WP4673,0.8505015694296619,0.5896681680301499,0.09548438966258406,"['INSR', 'ARNTL']",0.965430076284764,0,0,2
352,Head and Neck Squamous Cell Carcinoma WP4674,0.8590534932472341,0.5761767876392382,0.0875351313035892,"['CDKN1A', 'DDIT4']",0.965430076284764,0,0,2
353,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.8608815440148253,0.507534516765286,0.07602784006204782,['ACSL1'],0.965430076284764,0,0,1
354,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8608815440148253,0.507534516765286,0.07602784006204782,['MAP2K6'],0.965430076284764,0,0,1
355,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8608815440148253,0.507534516765286,0.07602784006204782,['HDAC4'],0.965430076284764,0,0,1
356,Gastrin signaling pathway WP4659,0.8629206194817562,0.6128393484509741,0.09035248270696103,"['CDKN1A', 'PXN', 'STAT3']",0.965430076284764,0,0,3
357,Wnt signaling WP428,0.8671562336276912,0.5632850241545894,0.0802884607680319,"['CCND3', 'WNT5A']",0.965430076284764,0,0,2
358,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8710647304824938,0.48793809740555305,0.06735448090898782,['ACTG1'],0.965430076284764,0,0,1
359,Neural Crest Cell Migration in Cancer WP4565,0.8710647304824938,0.48793809740555305,0.06735448090898782,['STAT3'],0.965430076284764,0,0,1
360,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8710647304824938,0.48793809740555305,0.06735448090898782,['STAT3'],0.965430076284764,0,0,1
361,Ciliary landscape WP4352,0.8855375159729597,0.6748183023266444,0.08203122032053284,"['DOCK5', 'TBC1D4', 'IQGAP1', 'IQGAP2', 'DYNLL1', 'COX6C', 'CALM2']",0.9693228736313215,0,0,7
362,Fragile X Syndrome  WP4549,0.8877869913652484,0.6095811818703385,0.07255444883117303,"['GRIP1', 'GRM5', 'GRIN2B', 'HCN1']",0.9693228736313215,0,0,4
363,Glioblastoma signaling pathways WP2261,0.8889655751778307,0.527832674571805,0.06212419947375789,"['CDKN1A', 'MAP2K6']",0.9693228736313215,0,0,2
364,ATM Signaling Network in Development and Disease  WP3878,0.8892532482042583,0.4529444914060299,0.05316355136055724,['HDAC4'],0.9693228736313215,0,0,1
365,Interleukin-11 Signaling Pathway WP2332,0.8973631573146821,0.4372577025096919,0.04735266600660204,['STAT3'],0.9693228736313215,0,0,1
366,Microglia Pathogen Phagocytosis Pathway WP3937,0.8973631573146821,0.4372577025096919,0.04735266600660204,['C1QB'],0.9693228736313215,0,0,1
367,TGF-beta Receptor Signaling WP560,0.8973631573146821,0.4372577025096919,0.04735266600660204,['STAT3'],0.9693228736313215,0,0,1
368,IL-6 signaling pathway WP364,0.9048802550741657,0.4226166995397765,0.042241662802611324,['STAT3'],0.9693228736313215,0,0,1
369,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9048802550741657,0.4226166995397765,0.042241662802611324,['MAP1LC3A'],0.9693228736313215,0,0,1
370,p53 transcriptional gene network WP4963,0.9048802550741657,0.4226166995397765,0.042241662802611324,['CDKN1A'],0.9693228736313215,0,0,1
371,Energy Metabolism WP1541,0.9118477949622853,0.4089202774066298,0.037736060502851554,['ESRRA'],0.9693228736313215,0,0,1
372,IL-5 signaling pathway WP127,0.9118477949622853,0.4089202774066298,0.037736060502851554,['STAT3'],0.9693228736313215,0,0,1
373,B Cell Receptor Signaling Pathway WP23,0.9144094725142409,0.53440245432994,0.04781662542012748,"['BCL6', 'RASGRP3', 'MAP2K6']",0.9693228736313215,0,0,3
374,Leptin signaling pathway WP2034,0.9180802932490411,0.47766425535088375,0.04082616775934536,"['PTPN1', 'STAT3']",0.9693228736313215,0,0,2
375,Pancreatic adenocarcinoma pathway WP4263,0.9180802932490411,0.47766425535088375,0.04082616775934536,"['CDKN1A', 'STAT3']",0.9693228736313215,0,0,2
376,Regulation of Microtubule Cytoskeleton WP2038,0.9183058802823045,0.39607988165680474,0.03375580530555364,['STAT3'],0.9693228736313215,0,0,1
377,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9183058802823045,0.39607988165680474,0.03375580530555364,['GRIN2B'],0.9693228736313215,0,0,1
378,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9183058802823045,0.39607988165680474,0.03375580530555364,['STAT3'],0.9693228736313215,0,0,1
379,RANKL/RANK signaling pathway WP2018,0.9242916932830906,0.3840176917099994,0.030232780391686562,['MAP2K6'],0.972462675649208,0,0,1
380,T-cell receptor (TCR) signaling pathway WP69,0.9275826352121186,0.4601509162773985,0.03459110608318565,"['CD83', 'MAP3K8']",0.972462675649208,0,0,2
381,Endometrial cancer WP4155,0.9298397074159082,0.3726650423483003,0.02710879751333469,['CDKN1A'],0.972462675649208,0,0,1
382,ErbB signaling pathway WP673,0.9360382890524993,0.44386658345468416,0.02933909124144329,"['CDKN1A', 'NRG1']",0.972462675649208,0,0,2
383,22q11.2 copy number variation syndrome WP4657,0.939747856731232,0.35185185185185186,0.021865367910801146,['ARNTL'],0.972462675649208,0,0,1
384,Mesodermal commitment pathway WP2857,0.9435530946824994,0.4286862731962216,0.024907804883318046,"['BHLHE40', 'RPL38']",0.972462675649208,0,0,2
385,Genes related to primary cilium development (based on CRISPR) WP4536,0.9441650974404103,0.3422890345967269,0.01966595523817275,['DYNLL1'],0.972462675649208,0,0,1
386,EGF/EGFR signaling pathway WP437,0.9442455915566769,0.5482755640072607,0.03145401322431655,"['PLSCR1', 'RPS6KA5', 'LIMK2', 'STAT3', 'IQGAP1']",0.972462675649208,0,0,5
387,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9461850692426289,0.5150631681243926,0.028491798518963003,"['GRIP1', 'RPS6KA5', 'STAT3', 'GRIN2B']",0.972462675649208,0,0,4
388,DNA IR-damage and cellular response via ATR WP4016,0.9482590768314381,0.33322952351292434,0.01770366026322196,['BCL6'],0.972462675649208,0,0,1
389,IL-3 signaling pathway WP286,0.9482590768314381,0.33322952351292434,0.01770366026322196,['STAT3'],0.972462675649208,0,0,1
390,TGF-beta Signaling Pathway WP366,0.9505274273262936,0.4676934360102677,0.023729951992532444,"['CDKN1A', 'LIMK2', 'MAP2K6']",0.972462675649208,0,0,3
391,Amino Acid metabolism WP3925,0.9555699837974657,0.3164694280078895,0.014382673081936874,['SRM'],0.975121287813782,0,0,1
392,Integrated breast cancer pathway WP1984,0.958213484821893,0.45077793493635077,0.01924131260507159,"['FAU', 'BACH1', 'RASGRP3']",0.9753244399079981,0,0,3
393,Proteasome Degradation WP183,0.9696472545135383,0.28108700416392723,0.008663924705818619,['H2AFZ'],0.9844510293916076,0,0,1
394,16p11.2 proximal deletion syndrome WP4949,0.9739400751653426,0.26904192370640817,0.007104186974664623,['MAP2K6'],0.9862997207892684,0,0,1
395,Corticotropin-releasing hormone signaling pathway WP2355,0.9776267315065589,0.25798011512297225,0.005837405564950932,['TLR4'],0.9875267490408025,0,0,1
396,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9822037384973795,0.24298285540889092,0.004363126292780228,['SEC24D'],0.9896446759102384,0,0,1
397,DNA Repair Pathways Full Network WP4946,0.9868861490170484,0.22548605240912933,0.0029765504488010715,['APEX1'],0.991857867651895,0,0,1
398,Ciliopathies WP4803,0.991707232689609,0.20347394540942929,0.0016943974557066777,['CCDC65'],0.9941989594049095,0,0,1
399,mRNA Processing WP411,0.9946412938485066,0.26473892240482627,0.001422472812031619,"['LSM7', 'SNRPD1']",0.9946412938485066,0,0,2
